Abstract We previously demonstrated that canine erythrocytes express the P2X 7 receptor, and that the function and expression of this receptor is greatly increased compared with human erythrocytes. Using 86 Rb + (K + ) and organic cation flux measurements, we further compared P2X 7 in erythrocytes and mononuclear leukocytes from these species. Concentration response curves of BzATP-and ATP-induced 86 Rb + efflux demonstrated that canine P2X 7 was less sensitive to inhibition by extracellular Na + ions compared to human P2X 7 . In contrast, canine and human P2X 7 showed a similar sensitivity to the P2X 7 antagonists KN-62 and Mg 2+ . KN-62 and Mg 2+ also inhibited ATPinduced choline + uptake into canine and human erythrocytes. BzATP and ATP but not ADP or NAD induced ethidium + uptake into canine monocytes, T-and B-cells. ATP-induced ethidium + uptake was twofold greater in canine T-cells compared to canine B-cells and monocytes. KN-62 inhibited the ATP-induced ethidium + uptake in each cell type. P2X 7 -mediated uptake of organic cations was 40-and fivefold greater in canine erythrocytes and lymphocytes (T-and B-cells), respectively, compared to equivalent human cell types. In contrast, P2X 7 function was threefold lower in canine monocytes compared to human monocytes.
Introduction
P2X 7 receptors are ligand-gated ion channels comprised of trimeric subunits within the plasma membrane [1] that interact with intracellular macromolecules [2] to regulate various membrane and intracellular responses [3] . Activation of P2X 7 by adenosine 5′-triphosphate (ATP) or the most potent agonist, 2′-and 3′-0(4-benzoylbenzoyl) ATP (BzATP) results in the movement of K chlamydiae [7] , and cell death [8] . P2X 7 has become a potential therapeutic target in a number of inflammatory, infectious, neurological and bone disorders [9] [10] [11] , but progress in this field is limited by the difficulty in purifying large quantities of P2X 7 and the absence of a structural model. Much of the available structural data on P2X 7 has been derived from site-directed mutagenesis studies of recombinant P2X 7 and other P2X receptors [12] , and comparisons of P2X 7 between species [11] .
P2X 7 is predominately expressed on blood, bone and epithelial cells [13] . Studies with human peripheral blood using anti-P2X 7 antibodies and cation flux measurements demonstrate that P2X 7 is present, in increasing order of magnitude, on erythrocytes, B-cells, T-cells, natural killer cells, monocytes, dendritic cells and macrophages [14] [15] [16] . Similar studies in other species and comparisons between equivalent cell types from different species are limited. Recently, we have observed that canine erythrocytes express the P2X 7 and that the relative function of this receptor is at least 40-fold greater than that of human erythrocytes [17] . This difference in receptor function corresponded to increased amounts of P2X 7 present on the plasma membrane of canine erythrocytes compared to human erythrocytes [17] . The pharmacological properties of canine P2X 7 however have only been partly characterised. Canine P2X 7 is activated by BzATP and ATP, and to a lesser extent 2-methylthio-ATP and adenosine 5′-0-(3-thiotriphosphate), but not adenosine 5′-diphosphate (ADP) nor uridine 5′-triphosphate [17] . Moreover, canine P2X 7 can be inhibited by KN-62, oxidised ATP, Brilliant blue G or a phthalazinamine derivative, termed compound 18, each applied at concentrations conventionally used to impair either human or rat P2X 7 [17, 18] . Whether canine P2X 7 can be impaired by ions such as Na + and Mg 2+ , as shown for other mammalian P2X 7 receptors [4] , is unknown. Therefore, using measurements of nucleotide-induced 86 Rb + (K + ) efflux from erythrocytes, we further characterised and compared the pharmacological properties of canine and human P2X 7 . Moreover, we compared the relative amounts of functional P2X 7 on erythrocytes and mononuclear leukocytes from both species using measurements of nucleotide-induced uptake of the organic cations, choline + and ethidium + , respectively.
Experimental procedures
Reagents ATP, BzATP, ADP, β-nicotinamide adenine dinucleotide (NAD), ethidium bromide, MgCl 2 , dimethyl sulphoxide (DMSO), Drabkin's reagent, bovine serum albumin (BSA) and other general reagent grade chemicals were from Sigma (St. Louis, MO). KN-62 was from Alexis Biochemicals (Lausen, Switzerland). Ficoll-Paque PLUS was from GE Healthcare Biosciences AB (Uppsala, Sweden). Rubidium-86 ( 86 Rb + ), SOLVABLE™ tissue solubilizer and Ultima Gold™ were from PerkinElmer Life Sciences (Boston, MA). [Methyl-
14 C]choline Cl was from GE Healthcare UK Ltd (Little Chalfont, Buckinghamshire, UK). Di-n-butyl phthalate and di-isooctyl phthalate (BDH Chemicals, Poole, England) were blended 80: 20 (v:v) to give an oil mixture of density 1.03 g/ml. Fluorescein isothiocyanate (FITC)-conjugated murine anti-human CD3 (clone UCHT1), CD14 (clone TUK4), which cross-reacts with canine CD14, and CD19 (clone HD37) monoclonal antibodies (mAb) were from Dako (Carpinteria, CA). Murine anti-canine CD3 (clone CA17.2A12) and B-cell (clone CA2.1D6) mAb were from AbD Serotec (Serotec, Oxford, United Kingdom). FITC-conjugated, F(ab) 2 fraction sheep anti-murine immunoglobulin secondary antibody was from Chemicon (Boronia, Australia).
Erythrocytes and mononuclear leukocytes This study was approved by the Westmead Hospital Animal Ethics (Westmead, Australia) and Sydney West Area Health Service Human Ethics (Penrith, Australia) Committees. Peripheral blood was collected in heparin-containing vacutainer tubes from adult English Springer spaniels and healthy adult human volunteers. Blood was centrifuged at 580×g for 15 min, and the plasma and platelets discarded, and leukocytes and the upper 10% of erythrocytes collected to obtain buffy coats. The remaining erythrocytes were washed twice in NaCl medium (147.5 mM NaCl, 2.5 mM KCl, 5 mM Dglucose, 0.1% BSA, 20 mM HEPES, pH 7.5) at 450×g for 5 min. To isolate mononuclear leukocytes, buffy coats were diluted in five volumes of NaCl medium, underlaid with Ficoll-Paque PLUS and centrifuged at 580×g for 30 min. Isolated mononuclear leukocytes were washed in NaCl medium at 450×g for 10 min. 86 Rb + efflux measurements Erythrocytes were loaded with 86 Rb + (5 μCi/ml) at a haematocrit of 40% (v:v) in NaCl medium for 4 h at 37°C. Cells were then washed three times with ice-cold NaCl medium at 4°C (1800×g for 3 min) and resuspended in either NaCl medium or KCl medium (150 mM KCl, 5 mM D-glucose, 0.1% BSA, 20 mM HEPES, pH 7.5) at a final haematocrit of 5% (v:v). 86 Rb + -loaded erythrocyte suspensions were incubated in the absence or presence of ATP or BzATP at 37°C. At 4 (canine) or 60 (human) min, 1 ml samples were overlaid on 300 μl of phthalate oil mixture and centrifuged at 8,000×g for 30 s. Previous studies have demonstrated that ATPinduced cation fluxes in canine and human erythrocytes at these time points are within the linear response ranges and allow for the detection of significant differences between treatments [16, 17, 19] . For studies using 14 C]choline + uptake, 50 μl aliquots of erythrocyte pellets were incubated with 1 ml SOLVABLE tissue solubilizer for 1 h at 60°C, followed by incubation with 100 μl 100 mM ethylenediaminetetraacetic acid and 500 μl 30% H 2 O 2 for 30 min at room temperature and then for a further 30 min at 60°C, before the addition of 10 ml Ultima Gold™. The level of radioactivity was measured using a Packard (Meriden, CT) Tri-Carb 2100TR Liquid Scintillation Analyser. The haemoglobin content of erythrocyte pellets (50 μl) was measured spectrophotometrically using Drabkin's reagent according to the manufacturer's instructions. The haemoglobin content was used to determine the level of choline + uptake per ml of canine and human erythrocytes based on mean cell haemoglobin concentrations of 5.4 and 5.2 μmol Hb/ml, respectively.
Ethidium
+ uptake measurements Mononuclear leukocytes were pre-labelled with FITC-conjugated mAb or mAb with FITC-conjugated secondary antibody, and resuspended in 1 ml KCl medium (2×10 6 cells/ml) at 37°C. At 0 s, 25 μM ethidium + was added, followed 40 s later by the addition of ATP as indicated. In some experiments, cells were preincubated for 5 min at 37°C in the presence of 1 μM KN-62 or an equal volume of DMSO. Data was collected using a Becton Dickinson (San Jose, CA) FACSCalibur flow cytometer over 6 min at 37°C with constant stirring using a Cytek (Fremont, CA) Time Zero Module. The linear mean channel of ethidium + fluorescence intensity for each gated population over successive 5 s intervals was analysed by WinMDI 2.8 Software developed by Joseph Trotter (http:// www.scripps.edu) and plotted against time. Agonistinduced ethidium + uptake was quantified as the difference in arbitrary units of area under the uptake curves in the presence and absence of agonist in the first 5 min of incubation as described [20] .
Statistical analyses Results are represented as means with standard error of the mean (SEM). Differences between treatments were compared using either the unpaired Student's t test for single comparisons or one-way analysis of variance for multiple comparisons with Bonferroni's post test using Prism 5 for Mac OS X Version 5.0a (GraphPad Software, San Diego, CA) with P<0.05 considered significant. Concentration response curves were plotted, and EC 50 values and Hill coefficients determined using Prism 5 for Mac OS X Version 5.0a.
Results
Canine P2X 7 is less sensitive to inhibition by extracellular Na + ions compared to human P2X 7 The relative potency of BzATP and ATP on human and rodent P2X 7 is reduced in the presence of extracellular Na + ions [21, 22] , however, the effect extracellular Na + ions on canine P2X 7 is unknown. Therefore, the BzATP-and ATP-induced efflux of 86 Rb + from canine and human erythrocytes in KCl medium (nominally free of Na + ions) and NaCl medium was measured (Fig. 1) . The data is summarised in Table 1 . As previously observed [17] , the rate of BzATP-and ATPinduced 86 Rb + efflux from canine erythrocytes was approximately 100-fold more than that from human erythrocytes. The EC 50 values for both canine and human P2X 7 to either agonist were higher in the presence of extracellular Na + ions. Moreover, efflux rates and maximum responses to BzATP and ATP were lower in NaCl medium compared to KCl medium for both canine and human receptors. Canine P2X 7 however was less sensitive to the inhibitory effects of extracellular Na + ions. The average rates of BzATP-and ATP-induced 86 Rb + efflux from canine erythrocytes were 5% and 28%, respectively, slower in NaCl medium compared to KCl medium; while the average rates of BzATP-and ATP-induced 86 Rb + efflux from human erythrocytes were 29% and 56%, respectively, slower in NaCl medium compared to KCl medium. In addition, the average maximum responses for BzATP-and ATP-induced 86 Rb + efflux from canine erythrocytes were 15% and 21%, respectively, lower in NaCl medium compared to KCl medium; while the average maximum responses for BzATP-and ATP-induced 86 Rb + efflux from human erythrocytes were 24% and 56%, respectively, lower in NaCl medium compared to KCl medium.
Sensitivity to KN-62 and extracellular Mg
2+ is similar between canine and human P2X 7 We have previously determined that the human P2X 7 inhibited ATP-induced 86 Rb + efflux from both canine and human erythrocytes in a similar and concentrationdependent fashion, and was maximal at 1 mM with near 100% inhibition in both species (Fig. 2b) . Again, the IC 50 for Mg 2+ for canine and human erythrocytes were similar (113±24 μM verses 52±22 μM respectively; P=0.13).
KN-62 and Mg
2+ inhibit ATP-induced choline + influx into canine and human erythrocytes We have previously shown that ATP can induce the uptake of choline + into both canine and human erythrocytes [17] ; however, a direct role for P2X 7 in this process was not demonstrated. Therefore, canine and human erythrocytes were resuspended in choline Cl medium (containing [ 14 C]choline + ) and incubated with 1 mM ATP for 12 and 60 min, respectively. ATP induced choline + uptake into erythrocytes from both species incubated in the absence of KN-62 and Mg 2+ (Fig. 3) . The rate of uptake was approximately 40-fold greater in canine erythrocytes compared to human erythrocytes. KN-62 (1 μM) inhibited the ATP-induced choline + influx into canine and human erythrocytes by 94±0% and 84±8%, respectively (Fig. 3a, c) . Similarly, Mg 2+ (10 mM) inhibited the ATPinduced choline + influx into canine and human erythrocytes by 100±0% and 84±3%, respectively (Fig. 3b, d ). Both KN-62 and Mg 2+ had minimal effect on the basal choline + uptake.
ATP-induced ethidium + uptake differs between canine and human monocytes and lymphocytes We have previously demonstrated that the ATP-induced ethidium + uptake, via activation of P2X 7 , is approximately fivefold greater in human monocytes compared to human T-and B-cells [15, 20] . In addition, we have previously shown that the ATPinduced ethidium + uptake is approximately threefold lower in canine monocytes compared to human monocytes [17] . Whether canine T-and B-cells express P2X 7 , and how the function of this receptor on these cells compares to canine monocytes or human leukocytes are unknown. Therefore, the ATP-induced ethidium + uptake into canine and human mononuclear leukocytes was measured as described [20] . ATP (1 mM) induced ethidium + uptake into all three canine and human leukocyte subpopulations ( Fig. 4; Table 2 ). ATP-induced ethidium + uptake into canine T-cells was approximately twofold greater than that into canine monocytes and B-cells. In contrast, but similar to our previous observations [15, 20] Fig. 5 ) similar to that of ATP-induced ethidium + uptake (Table 2 ). In contrast, the ability of ADP to induce ethidium + uptake into canine monocytes, T-and B-cells was negligible (221±138, 82±23 and 33±17 arbitrary units of uptake, respectively; Fig. 5 ).
Previous studies by Seman et al. have demonstrated that NAD, at a maximum concentration of 300 μM, can induce cation fluxes in murine T-cells via ADP-ribosylation of P2X 7 [25] . Therefore, the ability of NAD to induce ethidium + uptake in canine leukocytes was also examined. In contrast to ATP and BzATP, the ability of 300 μM NAD to induce ethidium + uptake into canine monocytes, T-and B-cells was negligible (32±26, 10±12 and 38±2 arbitrary units of uptake respectively; Fig. 5) .
Finally, to confirm that P2X 7 activation mediates ATPinduced ethidium + uptake into canine leukocytes, cells were pre-incubated with 1 μM KN-62 and the ATP-induced ethidium + uptake measured. KN-62 inhibited the ATPinduced ethidium + uptake into canine monocytes, T-and Bcells by 99±0%, 98±1% and 95±1%, respectively (Fig. 6 ). KN-62 had no effect on basal ethidium + uptake (results not shown).
Discussion
This study confirms previous reports that P2X 7 is present on canine and human erythrocytes [16-19, 26, 27] , and extends our knowledge regarding the pharmacological characteristics of canine P2X 7 efflux measurements from canine and human erythrocytes to characterise and compare P2X 7 in these two species. It is worth noting however, that this assay most likely examines the large permeability state (pore) of P2X 7 rather than the channel, as ATP-induced 86 Rb + efflux is impaired in human erythrocytes from subjects coding the Glu 496 Ala polymorphism [16] which impairs P2X 7 pore formation [28] , but not the ion channel properties of the receptor [29] . Consistent with our previous observations [17] , the rate of BzATP-and ATP-induced 86 Rb + efflux from canine erythrocytes was approximately 100-fold greater than from human erythrocytes. Moreover, as previously observed for human and rat P2X 7 [23, 30] , ATP was a partial agonist compared to BzATP. This phenomenon however is not common to all mammalian species. Both BzATP-and ATPinduced responses for murine P2X 7 are similar in magnitude [31] , while BzATP is a partial agonist of guinea pig P2X 7 compared to ATP [32] . The Hill coefficients, on average, were higher for canine erythrocytes compared to human erythrocytes indicating a greater degree of cooperativity for multiple agonist-binding sites for canine P2X 7 compared to human P2X 7 .
On average, EC 50 values were one order of magnitude lower for BzATP compared to ATP for both canine and human P2X 7 , consistent with our previous observations [16, 17] [33] .
Comparison of published sequences of canine and human P2X 7 [23, 34] demonstrate that these receptors contain a threonine and asparagine at residue 284 respectively. Although we have not directly sequenced the P2X 7 of the canine donors used in our study, we suggest that the residue difference at position 284 in these two species accounts for the observed differences in EC 50 values for ATP.
Examination of concentration response curves for ATP and BzATP for canine and human P2X 7 allowed us to compare the receptor activation in the presence or absence of extracellular Na + ions. Inhibition of P2X 7 by extracellular Na + ions is a well-described event [21, 22] , which is thought to occur via a regulatory Na + binding site on the extracellular loop of the receptor within the electrical field of the membrane [35] . EC 50 values for both canine and human P2X 7 to either agonist were higher in the presence of extracellular Na + . Moreover, efflux rates and maximum responses to ATP and BzATP were lower in NaCl medium compared to KCl medium for both canine and human receptors. Canine P2X 7 however was less sensitive to the inhibitory effects of extracellular Na + ions, as the percentage decreases in efflux rates and maximum responses in the presence of extracellular Na + ions were smaller for canine P2X 7 compared to human P2X 7 . We cannot exclude the possibility that the increased 86 Rb + (K + ) efflux in KCl medium compared to NaCl medium was due to increased cytosolic Ca 2+ via KCl-induced activation of N-type Ca 2+ channels and the subsequent activation of the Gardos channel. Although the KCl medium used in our study was nominally free of Ca 2+ , it would be of interest to assess ATP-induced 86 Rb + efflux from erythrocytes in the presence and absence of a N-type Ca 2+ channel blocker such as ω-conotoxin GVIA.
KN-62 inhibited canine P2X 7 in a concentrationdependent fashion, as previously observed for human P2X 7 in B-cells [36] . The IC 50 for canine P2X 7 was relatively similar to that of human P2X 7 in comparison to the IC 50 values for mouse and rat P2X 7 which are ten-and 100-fold greater than for human P2X 7 , respectively [37] . Sensitivity to KN-62 between the human and rat P2X 7 can be largely explained by differences at residue 95 in the receptor, which contain phenylalanine and lysine, respectively [38] . Canine P2X 7 also contains a phenylalanine at this position [34] , consistent with the KN-62 sensitivity of this receptor.
Mg 2+ ions inhibited canine P2X 7 in a concentrationdependent fashion, as previously observed for recombinant human and rat P2X 7 [21, 23, 24] and similar to that for human erythrocyte P2X 7 . The ability of Mg 2+ to impair P2X 7 is a well-established phenomenon [39] , although its mechanism of action remains unknown. It has long been considered that Mg 2+ chelates ATP 4− , the active form of the agonist, thereby inhibiting P2X 7 [39] . More recent data, however, demonstrates that Mg 2+ binds to the positively charged residues, histidine 130 and histidine 201 of rat P2X 7 to impair receptor function [40] . In this regard, histidine 201 is present in canine P2X 7 , as well as human P2X 7 , while an uncharged serine exists at position 130 in P2X 7 from these species [23, 34] . Thus, Mg 2+ may also impair canine and human P2X 7 by directly binding to this conserved histidine, and may explain the similarity in IC 50 values for Mg 2+ between these species. Direct comparison between the two species, however, is complicated by the use of different ATP concentrations, and hence differences in the concentrations of available Mg 2+ and ATP 4− to inhibit and activate the receptor, respectively. The data were derived from uptake into murine macrophages [41] , human lymphocytes [42] , and canine and human erythrocytes [17] , however, a direct role for P2X 7 in these processes has never been formally demonstrated. The observation that KN-62 and Mg 2+ impair this process in erythrocytes provides the first direct evidence that P2X 7 activation is responsible for ATPinduced choline + uptake in cells. Choline + is an important nutrient in Plasmodium-infected erythrocytes, and the mechanisms that mediate its uptake are unknown but are potential therapeutic targets in malaria [43] . P2Y 1 , via the autocrine release of ATP, is involved in the induction of an osmolyte permeability pathway in Plasmodium-infected erythrocytes [44] , and thus the autocrine-induced activation of P2X 7 may play a similar role in choline + uptake in Plasmodium-infected erythrocytes.
This study demonstrated the presence of functional P2X 7 on canine monocytes, T-and B-cells. Both ATP and BzATP induced ethidium + uptake into to each of these leukocyte subpopulations, while ADP, which does not activate P2X 7 [4] ATP-induced ethidium + uptake into canine monocytes, Tand B-cells. P2X 7 function, as determined by measurements of ATP-induced ethidium + uptake, was approximately twofold greater in canine T-cells compared to canine monocytes and B-cells. This contrasts the relative differences in P2X 7 function in the equivalent human leukocyte subpopulations, where P2X 7 function is at least fivefold greater in human monocytes compared to human T-and Bcells [15, 20] . Moreover, P2X 7 function was approximately threefold lower in canine monocytes compared to human monocytes, but fivefold higher in canine T-and B-cells compared to human T-and B-cells. In comparison, P2X 7 function, as assessed by choline + uptake, was 40-fold greater in canine erythrocytes compared to human erythrocytes. Although the possibility remains that ethidium + and choline + uptake are mediated by different permeability pathways [45] , the results nevertheless show striking differences in the amounts of P2X 7 -mediated uptake of organic cations in equivalent cell subsets between the two species. Differences in P2X 7 expression in canine monocytes, T-and B-cells are most likely responsible for the observed differences in P2X 7 functions in these cells. As stated above, the relative differences in P2X 7 function between canine and human erythrocytes corresponds with differences in P2X 7 expression [17] , while in human leukocytes P2X 7 function corresponds to P2X 7 expression [15, 46] .
NAD was unable to activate P2X 7 in canine leukocytes despite being used at a concentration (300 μM) maximal for murine P2X 7 activation [25] and being able to stimulate ethidium + uptake into lymph node T-cells from C57Bl/6 mice (unpublished observations). NAD can induce cation fluxes in murine T-cells via ADP-ribosylation of P2X 7 , a process that requires the co-expression of ADPribosyltransferases on the cell surface [25] . Thus, the most likely explanation for the inability of NAD to stimulate ethidium + uptake in canine leukocytes is the absence of this ecto-enzyme on canine monocytes, T-and B-cells. The inability of NAD to activate canine P2X 7 was not due to the absence of the ADP-ribosylation site as canine P2X 7 also contains arginine 125 [34] , which is the same residue ribosylated by ADP in murine P2X 7 [47] .
Our data demonstrates pharmacological similarities and differences between the canine and human P2X 7 . Thus, future studies aimed at identifying residues and domains mediating pharmacological similarities and differences between these two species may contribute to our understanding of the structure and function of this receptor. Moreover, P2X 7 is attracting much interest as a potential therapeutic target in a number of inflammatory, infectious, neurological and bone disorders in humans [9] [10] [11] . Thus, identification of functional P2X 7 in canines and in particular in various canine leukocyte subpopulations offers a potential therapeutic target in canine disorders equivalent to those in humans.
